Medscape March 7, 2025
Lucy Hicks

A new artificial intelligence (AI) tool can simultaneously assess blood samples for infections, autoimmune diseases, and vaccine responses, according to a new study.

The algorithm analyzed genes encoding immune cell receptors to identify patients with COVID-19, HIV, type 1 diabetes, lupus, those who recently received a flu vaccination, and healthy controls.

These receptor sequences are “unique sources of potential diagnostic information,” said Scott Boyd, MD, PhD, a professor of pathology at Stanford University, Stanford, California, and one of the senior authors of the paper. “They haven’t really been used to diagnose anything apart from cancers that are derived from B cells and T cells at present.”

While the study, published in Science on February 21, is a proof of concept,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Patient / Consumer, Provider, Survey / Study, Technology, Trends
AI’s Eye-Popping Price Tags: The New Tech Gold Rush
Google’s Gemini AI Could Soon Gain Full Access To Your Search History
How Yelp reviewed competing LLMs for correctness, relevance and tone to develop its user-friendly AI assistant
Mistral AI CEO Arthur Mensch: Open Source Enables Cost-Effective, Powerful AI
AI governance 'no small task': Inside evolving structures for 3 health systems

Share This Article